Selskabets formål er produktion og salg af medicinalvarer.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 301.2 mio. | 30.8 mio. | 454.8 mio. | 406.5 mio. | 46 | |
CVR: 39640163
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Companies in the same industry and area
CVR 66351912
CVR 35435778
CVR 36184779
CVR 28714084
CVR 38163566
Elanco Denmark ApS demonstrates a solid financial health with a consistent profitability trend, highlighted by a profit increase to 30,847,000 DKK in 2024, up from 27,998,000 DKK in 2023. However, revenue has seen a significant decline from 736,547,000 DKK in 2023 to 301,211,000 DKK in 2024, indicating potential challenges in maintaining sales momentum. The company's equity remains strong at 406,491,000 DKK, suggesting a robust capital position despite the revenue drop. Overall, while profitability is improving, the sharp decline in revenue raises concerns about its market position and operational stability within the pharmaceutical distribution industry.
AI-generated summary
companydata.dk